{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T18:27:10Z","timestamp":1773167230521,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,4,3]],"date-time":"2015-04-03T00:00:00Z","timestamp":1428019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s10689-015-9798-8","type":"journal-article","created":{"date-parts":[[2015,4,3]],"date-time":"2015-04-03T13:38:23Z","timestamp":1428068303000},"page":"383-391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study"],"prefix":"10.1007","volume":"14","author":[{"name":"Hereditary Breast Cancer Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yakir","family":"Segev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Lubinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Gronwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry T.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pal","family":"Moller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charmaine","family":"Kim-Sing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parviz","family":"Ghadirian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Karlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charis","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawna","family":"Gilchrist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Neuhausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eitan","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Euhus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun","family":"Ping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Narod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,3]]},"reference":[{"key":"9798_CR1","unstructured":"Ferlay J, Bray F, Forman D, Mathers C, Parkin DM. SHR (2010) Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. GLOBOCAN 2008, International Agency for Research on Cancer, Lyon, France. http:\/\/globocan.iarc.fr"},{"key":"9798_CR2","doi-asserted-by":"crossref","unstructured":"Furness S, Roberts H, Marjoribanks J, Lethaby A, Hickey M, Farquhar C (2009) Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev CD000402. doi: 10.1002\/14651858.CD000402.pub3","DOI":"10.1002\/14651858.CD000402.pub3"},{"key":"9798_CR3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0029-7844(00)01196-0","volume":"97","author":"MJ Mourits","year":"2001","unstructured":"Mourits MJ, De Vries EG, Willemse PH et al (2001) Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol 97:855","journal-title":"Obstet Gynecol"},{"key":"9798_CR4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569","journal-title":"Lancet"},{"key":"9798_CR5","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/sj.bjc.6605902","volume":"103","author":"SC Moore","year":"2010","unstructured":"Moore SC, Gierach GL, Schatzkin A, Matthews CE (2010) Physical activity, sedentary behaviours, and the prevention of endometrial cancer. Br J Cancer 103:933","journal-title":"Br J Cancer"},{"key":"9798_CR6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ijc.11598","volume":"108","author":"WH Xu","year":"2004","unstructured":"Xu WH, Xiang YB, Ruan ZX et al (2004) Menstrual and reproductive factors and endometrial cancer risk: results from a population-based case\u2013control study in urban Shanghai. Int J Cancer 108:613","journal-title":"Int J Cancer"},{"key":"9798_CR7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ijc.24672","volume":"126","author":"S Karageorgi","year":"2010","unstructured":"Karageorgi S, Hankinson SE, Kraft P, De Vivo I (2010) Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses\u2019 Health Study cohort 1976\u20132004. Int J Cancer 126:208","journal-title":"Int J Cancer"},{"key":"9798_CR8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/CEJ.0b013e328305a0c9","volume":"18","author":"E Lucenteforte","year":"2009","unstructured":"Lucenteforte E, Talamini R, Montella M et al (2009) Family history of cancer and the risk of endometrial cancer. Eur J Cancer Prev 18:95","journal-title":"Eur J Cancer Prev"},{"key":"9798_CR9","first-page":"1531","volume":"20","author":"O Lavie","year":"2010","unstructured":"Lavie O, Ben-Arie A, Segev Y et al (2010) BRCA germline mutations in women with uterine serous carcinoma-still a debate. Int J Gynecol Cancer 20:1531\u20131534","journal-title":"Int J Gynecol Cancer"},{"key":"9798_CR10","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ejso.2006.03.032","volume":"32","author":"T Biron-Shental","year":"2006","unstructured":"Biron-Shental T, Drucker L, Altaras M, Bernheim J, Fishman A (2006) High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma. Eur J Surg Oncol 32:1097\u20131100","journal-title":"Eur J Surg Oncol"},{"key":"9798_CR11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/gyno.2000.6003","volume":"79","author":"R Goshen","year":"2000","unstructured":"Goshen R, Chu W, Elit L et al (2000) Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast\u2013ovarian cancer syndrome? Gynecol Oncol 79:477\u2013481","journal-title":"Gynecol Oncol"},{"key":"9798_CR12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2013.03.027","volume":"130","author":"Y Segev","year":"2013","unstructured":"Segev Y, Iqbal J, Lubinski J et al (2013) The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study. Gynecol Oncol 130:127\u2013131","journal-title":"Gynecol Oncol"},{"key":"9798_CR13","first-page":"418","volume":"20","author":"F Cosman","year":"1999","unstructured":"Cosman F, Lindsay R (1999) Selective estrogen receptor modulators: clinical spectrum. Endocr Rev 20:418","journal-title":"Endocr Rev"},{"key":"9798_CR14","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJM199811263392207","volume":"339","author":"CK Osborne","year":"1998","unstructured":"Osborne CK (1998) Tamoxifen in the treatment of breast cancer. N Engl J Med 339:1609","journal-title":"N Engl J Med"},{"key":"9798_CR15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1470-2045(06)70983-4","volume":"8","author":"JR McLaughlin","year":"2007","unstructured":"McLaughlin JR, Risch HA, Lubinski J et al (2007) Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case\u2013control study. Lancet Oncol 8:26","journal-title":"Lancet Oncol"},{"key":"9798_CR16","doi-asserted-by":"crossref","first-page":"R263","DOI":"10.1677\/ERC-10-0076","volume":"17","author":"AO Mueck","year":"2010","unstructured":"Mueck AO, Seeger H, Rabe T (2010) Hormonal contraception and risk of endometrial cancer: a systematic review. Endocr Relat Cancer 17:R263","journal-title":"Endocr Relat Cancer"},{"key":"9798_CR17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0960-0760(95)00084-D","volume":"53","author":"BS Katzenellenbogen","year":"1995","unstructured":"Katzenellenbogen BS, Montano MM, Le Goff P et al (1995) Antiestrogens: mechanisms and actions in target cells. J Steroid Biochem Mol Biol 53:387","journal-title":"J Steroid Biochem Mol Biol"},{"key":"9798_CR18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","volume":"378","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG), Davies C, Godwin J, et al","year":"2011","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG), Davies C, Godwin J et al (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378:771","journal-title":"Lancet"},{"key":"9798_CR19","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","volume":"97","author":"B Fisher","year":"2005","unstructured":"Fisher B, Costantino JP, Wickerham DL et al (2005) Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 97:1652","journal-title":"J Natl Cancer Inst"},{"key":"9798_CR20","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jnci\/djn313","volume":"100","author":"A Eisen","year":"2008","unstructured":"Eisen A, Lubinski J, Gronwald J et al (2008) Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers. J Natl Cancer Inst 100:1361\u20131367","journal-title":"J Natl Cancer Inst"},{"key":"9798_CR21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ygyno.2005.07.110","volume":"100","author":"J Kotsopoulos","year":"2006","unstructured":"Kotsopoulos J, Lubinski J, Neuhausen SL et al (2006) Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Gynecol Oncol 100:83\u201388","journal-title":"Gynecol Oncol"},{"key":"9798_CR22","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/S0002-9378(89)80007-9","volume":"161","author":"BE Henderson","year":"1989","unstructured":"Henderson BE (1989) The cancer question: an overview of recent epidemiologic and retrospective data. Am J Obstet Gynecol 161:1859","journal-title":"Am J Obstet Gynecol"},{"key":"9798_CR23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmj.298.6667.147","volume":"298","author":"I Persson","year":"1989","unstructured":"Persson I, Adami HO, Bergkvist L et al (1989) Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. BMJ 298:147","journal-title":"BMJ"},{"key":"9798_CR24","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/oxfordjournals.aje.a008707","volume":"143","author":"CP McPherson","year":"1996","unstructured":"McPherson CP, Sellers TA, Potter JD et al (1996) Reproductive factors and risk of endometrial cancer. The Iowa Women\u2019s Health Study. Am J Epidemiol 143:1195","journal-title":"Am J Epidemiol"},{"key":"9798_CR25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1600-0412.1997.tb07996.x","volume":"76","author":"ML L\u00f8chen","year":"1997","unstructured":"L\u00f8chen ML, Lund E (1997) Childbearing and mortality from cancer of the corpus uteri. Acta Obstet Gynecol Scand 76:37","journal-title":"Acta Obstet Gynecol Scand"},{"key":"9798_CR26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.amjmed.2008.01.044","volume":"121","author":"B Zhou","year":"2008","unstructured":"Zhou B, Yang L, Sun Q et al (2008) Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med 121:501","journal-title":"Am J Med"},{"key":"9798_CR27","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S1470-2045(13)70448-0","volume":"14","author":"M Widschwendter","year":"2013","unstructured":"Widschwendter M, Rosenthal AN, Philpott S et al (2013) The sex hormone system in carriers of BRCA1\/2 mutations: a case\u2013control study. Lancet Oncol 14:1226\u20131232","journal-title":"Lancet Oncol"},{"key":"9798_CR28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1006\/dbio.1997.8526","volume":"184","author":"JV Rajan","year":"1997","unstructured":"Rajan JV, Marquis ST, Gardner HP, Chodosh LA (1997) Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Dev Biol 184:385\u2013401","journal-title":"Dev Biol"},{"key":"9798_CR29","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1158\/0008-5472.CAN-04-1283","volume":"64","author":"TA King","year":"2004","unstructured":"King TA, Gemignani ML, Li W et al (2004) Increased progesterone receptor expression in benign epithelium of BRCA-1 related breast cancers. Cancer Res 64:5051\u20135053","journal-title":"Cancer Res"},{"key":"9798_CR30","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/sj.onc.1208190","volume":"24","author":"YX Ma","year":"2005","unstructured":"Ma YX, Tomita Y, Fan S et al (2005) Structural determinants of the BRCA1: estrogen receptor interaction. Oncogene 24:1831\u20131846","journal-title":"Oncogene"},{"key":"9798_CR31","doi-asserted-by":"crossref","first-page":"e006","DOI":"10.1621\/nrs.04006","volume":"4","author":"P Katiyar","year":"2006","unstructured":"Katiyar P, Ma Y, Fan S, Pestell RG, Furth PA, Rosen EM (2006) Regulation of progesterone receptor signaling by BRCA1 in mammary cancer. Nucl Recept Signal 4:e006","journal-title":"Nucl Recept Signal"},{"key":"9798_CR32","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","volume":"31","author":"VW Setiawan","year":"2013","unstructured":"Setiawan VW, Yang HP, Pike MC et al (2013) Type I and II endometrial cancers: Have they different risk factors? J Clin Oncol 31:2607\u20132618","journal-title":"J Clin Oncol"},{"key":"9798_CR33","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2013.49.3122","volume":"31","author":"K Visvanathan","year":"2013","unstructured":"Visvanathan K, Hurley P, Bantug E et al (2013) Use of pharmacologic interventions for breast cancer risk reduction: American society of clinical oncology clinical practice guideline. J Clin Oncol 31:2942\u20132962","journal-title":"J Clin Oncol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-015-9798-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-015-9798-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-015-9798-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T21:46:15Z","timestamp":1559252775000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-015-9798-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["9798"],"URL":"https:\/\/doi.org\/10.1007\/s10689-015-9798-8","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,3]]}}}